IN2013DN11328A - - Google Patents

Download PDF

Info

Publication number
IN2013DN11328A
IN2013DN11328A IN11328DEN2013A IN2013DN11328A IN 2013DN11328 A IN2013DN11328 A IN 2013DN11328A IN 11328DEN2013 A IN11328DEN2013 A IN 11328DEN2013A IN 2013DN11328 A IN2013DN11328 A IN 2013DN11328A
Authority
IN
India
Prior art keywords
turmerone
disorders
treatment
turmeric oil
abolene
Prior art date
Application number
Other languages
English (en)
Inventor
Witte Peter A M De
Camila V Esguerra
Alexander D Crawford
Paucar Adriana Monserrath Orellana
Original Assignee
Univ Leuven Kath
Univ De Cuenca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leuven Kath, Univ De Cuenca filed Critical Univ Leuven Kath
Publication of IN2013DN11328A publication Critical patent/IN2013DN11328A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IN11328DEN2013 2011-07-04 2012-07-04 IN2013DN11328A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1111319.8A GB201111319D0 (en) 2011-07-04 2011-07-04 Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
PCT/EP2012/063027 WO2013004740A1 (en) 2011-07-04 2012-07-04 Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids

Publications (1)

Publication Number Publication Date
IN2013DN11328A true IN2013DN11328A (ko) 2015-05-15

Family

ID=44512006

Family Applications (1)

Application Number Title Priority Date Filing Date
IN11328DEN2013 IN2013DN11328A (ko) 2011-07-04 2012-07-04

Country Status (7)

Country Link
US (1) US9782361B2 (ko)
EP (1) EP2729138B8 (ko)
JP (1) JP6090867B2 (ko)
ES (1) ES2661844T3 (ko)
GB (1) GB201111319D0 (ko)
IN (1) IN2013DN11328A (ko)
WO (1) WO2013004740A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101517843B1 (ko) 2013-09-30 2015-05-08 한국인스팜(주) 울금 비극성용매 가용 추출물 또는 이로부터 분리된 아로매틱-튜메론을 유효성분으로 함유하는 스트레스관련 질환의 치료 및 예방을 위한 조성물
JP6773361B2 (ja) * 2015-04-09 2020-10-21 ハウスウェルネスフーズ株式会社 気分状態改善剤
JP6883845B2 (ja) * 2017-03-17 2021-06-09 学校法人早稲田大学 アストロサイト分化促進用組成物
CN110721175A (zh) * 2018-07-17 2020-01-24 文小燕 姜黄提取物在制备治疗癫痫的药物中的用途
FR3098396B1 (fr) * 2019-07-10 2022-07-29 Indigo Therapeutics Composition pour le traitement des troubles des émotions
CN113759007B (zh) * 2020-08-25 2023-03-21 北京康仁堂药业有限公司 一种广西莪术的质量控制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002348802A1 (en) 2001-12-14 2003-06-30 Council Of Scientific And Industrial Research Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders
US20040254146A1 (en) * 2002-05-21 2004-12-16 Nastech Pharmaceutical Company Inc. Carboxylate salts of galantamine and their pharmaceutical use
JP2004331539A (ja) * 2003-05-06 2004-11-25 Maruzen Pharmaceut Co Ltd 肝臓疾患予防治療剤及び肝臓疾患予防治療用飲食物
US20080193573A1 (en) * 2006-03-17 2008-08-14 Gow Robert T Extracts and methods comprising curcuma species
CN101199833B (zh) 2007-12-21 2011-03-16 北京中科雍和医药技术有限公司 一种缓解关节炎疼痛的复方精油
TW201019949A (en) 2008-10-16 2010-06-01 Herbalscience Group Llc Extracts of curcuma and methods of use thereof
ES2547730T3 (es) * 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Inhibidores del deterioro cognitivo
CN102695445B (zh) 2009-12-31 2016-04-13 阿塞里克股份有限公司 包括微过滤器的洗碗机
BR112012022983A2 (pt) 2010-03-15 2015-09-15 Laila Nutraceuticals óleo de bosvélia, sua frações e composições para melhoria do funcionamento cerebral
DK2555787T3 (da) 2010-04-05 2018-01-29 Benny Antony Formulering af curcumin med forbedret biotilgængelighed af curcumin samt fremgangsmåde til fremstilling deraf og behandling dermed

Also Published As

Publication number Publication date
US9782361B2 (en) 2017-10-10
ES2661844T3 (es) 2018-04-04
US20140243420A1 (en) 2014-08-28
JP2014518241A (ja) 2014-07-28
WO2013004740A1 (en) 2013-01-10
GB201111319D0 (en) 2011-08-17
EP2729138A1 (en) 2014-05-14
EP2729138B1 (en) 2017-12-13
JP6090867B2 (ja) 2017-03-08
EP2729138B8 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
IN2013DN11328A (ko)
CL2015000096A1 (es) Compuestos derivados de 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos, inhibidores de fosfodiestearasa 2 y/o 10; composicion farmaceutica; y su uso para prevencion o tratamiento de enfermedades del sistema nervioso, como deficiencia cognitiva, demencia, trastornos de ansiedad, enf. de alzheimer, enf. de parkinson, otros
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
GB201111712D0 (en) Pharmaceutical compositions
AU2018247351B2 (en) Methods and compositions for treatment of demyelinating diseases
GEP20186928B (en) Binding molecules for bcma and cd3
MX2014002459A (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
EA201590655A1 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
PH12014502218A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012277802A8 (en) Novel inhibitor compounds of phosphodiesterase type 10A
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
NZ773177A (en) Neuroactive steroid formulations and methods of treating cns disorders
MX356865B (es) Nuevas soluciones terapéuticas para tratar la enfermedad de parkinson.
MY166890A (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012286851A8 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
CY1118966T1 (el) Νεες συνθεσεις για την προληψη και/ή την θεραπεια εκφυλιστικων διαταραχων του κεντρικου νευρικου συστηματος
UA109260C2 (uk) Хромонові похідні, спосіб їх одержання та їх терапевтичні застосування
CA2864606C (en) Methods of treating and preventing diseases and disorders of the central nervous system
MX2012010084A (es) Compuestos utiles para tratar transtornos neurodegenerativos.
MX2021007142A (es) Compuestos organicos.
MX2014014066A (es) Compuestos de cromano.
WO2009151683A3 (en) Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
MX343366B (es) Peptidos de nd2 y metodos de tratamiento de enfermedad neurologica.
IN2014DN10081A (ko)